| 000 | 01815 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514225745.0 | ||
| 264 | 0 | _c20051212 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1055-9965 | ||
| 024 | 7 |
_a10.1158/1055-9965.EPI-04-0783 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaugherty, Sarah E | |
| 245 | 0 | 0 |
_aNo evidence for anticipation in lymphoproliferative tumors in population-based samples. _h[electronic resource] |
| 260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cMay 2005 |
||
| 300 |
_a1245-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aBias |
| 650 | 0 | 4 | _aDatabases as Topic |
| 650 | 0 | 4 |
_aDenmark _xepidemiology |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aHodgkin Disease _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xepidemiology |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xepidemiology |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xepidemiology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xepidemiology |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aSweden _xepidemiology |
| 700 | 1 | _aPfeiffer, Ruth M | |
| 700 | 1 | _aMellemkjaer, Lene | |
| 700 | 1 | _aHemminki, Kari | |
| 700 | 1 | _aGoldin, Lynn R | |
| 773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 14 _gno. 5 _gp. 1245-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1055-9965.EPI-04-0783 _zAvailable from publisher's website |
| 999 |
_c15557213 _d15557213 |
||